April's Insider Flow简体 · 繁體
医疗保健 · Healthcare

ROIV · Roivant Sciences Ltd.

内部人交易(Form 4)· Insider trading · 2026-07-01 – 2026-10-22

Roivant Sciences Ltd.(ROIV)内部人交易:2026-07-01 至 2026-10-22,内部人公开市场买入 —、卖出 $67.8M;高管董事有效买入 —、有效卖出 —。最近申报 2026-10-22。

买入 Bought—
卖出 Sold$67.8M
有效买入 Effective bought—
有效卖出 Effective sold—
打开互动页面(K 线、成交价图)Open interactive page →

最近申报 Recent filings

交易日内部人类型股数价格金额
2026-10-20Venker Eric
President & Immunovant CEO
卖出 Sell200,000$35.11$7.0MSEC
2026-10-01Epperly Melissa B,
Director
卖出 Sell17,750$36.10$641KSEC
2026-09-30Venker Eric
President & Immunovant CEO
卖出 Sell200,000$36.62$7.3MSEC
2026-09-15Epperly Melissa B,
Director
卖出 Sell4,938$39.74$196KSEC
2026-09-15Fitzgerald Meghan
Director
卖出 Sell5,112$39.74$203KSEC
2026-09-08Fitzgerald Meghan
Director
卖出 Sell20,000$39.90$798KSEC
2026-08-28Venker Eric
President & Immunovant CEO
卖出 Sell200,000$35.77$7.2MSEC
2026-08-19Sukhatme Mayukh
Director, President & CIO
卖出 Sell335,174$36.88$12.4MSEC
2026-08-14Sukhatme Mayukh
Director, President & CIO
卖出 Sell664,826$36.34$24.2MSEC
2026-07-27Venker Eric
President & Immunovant CEO
卖出 Sell200,000$34.95$7.0MSEC
2026-06-30Fitzgerald Meghan
Director
卖出 Sell10,000$34.90$349KSEC
2026-06-29Epperly Melissa B,
Director
卖出 Sell17,750$34.38$610KSEC
「有效」= 高管或董事的公开市场主动买卖,排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。

拟出售 Form 144

预计出售日申报人股数约金额
2026-10-20Venker Eric
Officer
200,000$7.0M10b5-1
2026-09-30Venker Eric
Officer
200,000$7.3M10b5-1
2026-09-15Epperly Melissa B,
Director
22,688$931K10b5-1
2026-09-15Fitzgerald Meghan
Officer
5,112$210K10b5-1
2026-09-08Fitzgerald Meghan
Director
20,000$699K10b5-1
2026-08-28Venker Eric
Officer
200,000$7.1M10b5-1
2026-08-21Sukhatme Mayukh
Officer, Director
144,756$5.3M
2026-08-20Sukhatme Mayukh
Officer, Director
17,519$653K
2026-08-19Sukhatme Mayukh
Officer, Director
172,899$6.4M
2026-08-18Sukhatme Mayukh
Officer, Director
136,942$5.0M

内部人 Insiders

Venker Eric、Epperly Melissa B,、Fitzgerald Meghan、Sukhatme Mayukh